<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39489519</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1326-5377</ISSN><JournalIssue CitedMedium="Internet"><Volume>221 Suppl 9</Volume><PubDate><Year>2024</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>The Medical journal of Australia</Title><ISOAbbreviation>Med J Aust</ISOAbbreviation></Journal><ArticleTitle>The economic burden of long COVID in Australia: more noise than signal?</ArticleTitle><Pagination><StartPage>S31</StartPage><EndPage>S39</EndPage><MedlinePgn>S31-S39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5694/mja2.52468</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To estimate the potential economic burden of long COVID in Australia.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A stock-and-flow model of weekly estimated numbers of people with long COVID (January 2021 to June 2023); application of proxy cost estimates from people living with myalgic encephalomyelitis/chronic fatigue syndrome; time series analysis of labour market and social security datasets.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The working age Australian population.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The likely number of Australians severely impacted by long COVID; the economic cost of long COVID; and the impacts of long COVID, determined by analysis of labour market data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At its peak in late 2022, between 181&#x2009;000 and 682&#x2009;000 Australians may have experienced some long COVID symptoms, of whom 40&#x2009;000-145&#x2009;000 may have been severely affected. Severe cases potentially decreased to affecting 10&#x2009;000-38&#x2009;000 people by June 2023. The likely economic burden of long COVID in Australia during 2022 was between $1.7 billion and $6.3 billion (some 0.07% to 0.26% of gross domestic product). Labour market data suggest that between 25&#x2009;000 (February 2023) and 103&#x2009;000 (June 2023) more working age Australians reported being unable to work due to long term sickness than would have been predicted based on pre-COVID-19 trends. This does not appear to have translated into increased claims for Disability Support Pensions, but numbers of working age Carer Allowance recipients have grown markedly since 2022.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long COVID likely imposed a small but significant aggregate toll on the Australian economy, while exposing tens of thousands of Australians to substantial personal economic hardship and contributing to labour market supply constraints. Yet while some signal from long COVID is discernible in the labour force data, Australia lacks adequate direct surveillance data to securely guide policy making.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Medical Journal of Australia published by John Wiley &amp; Sons Australia, Ltd on behalf of AMPCo Pty Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angeles</LastName><ForeName>Mary Rose</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0001-5660-9198</Identifier><AffiliationInfo><Affiliation>Deakin University, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinh</LastName><ForeName>Thi Thu Ngan</ForeName><Initials>TTN</Initials><Identifier Source="ORCID">0000-0003-2339-2628</Identifier><AffiliationInfo><Affiliation>University of Tasmania, Hobart, TAS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Tasmania, Hobart, TAS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Graaff</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Tasmania, Hobart, TAS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hensher</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6444-6827</Identifier><AffiliationInfo><Affiliation>University of Tasmania, Hobart, TAS.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Med J Aust</MedlineTA><NlmUniqueID>0400714</NlmUniqueID><ISSNLinking>0025-729X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="N">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004651" MajorTopicYN="N">Employment</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">Chronic disease</Keyword><Keyword MajorTopicYN="N">Economic models</Keyword><Keyword MajorTopicYN="N">Population health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39489519</ArticleId><ArticleId IdType="doi">10.5694/mja2.52468</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2010;146.</Citation></Reference><Reference><Citation>Office for National Statistics (UK). Prevalence&#xa0;of ongoing symptoms following coronavirus (COVID&#x2010;19) infection in the UK: 1 April 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021 (viewed Sep 2022).</Citation></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID&#x2010;19) infection in the UK: 30 March 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023 (viewed Apr 2023).</Citation></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, et&#xa0;al. Long COVID and significant activity limitation among adults, by age &#x2014; United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep 2023; 72: 866&#x2010;870.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et&#xa0;al. Global prevalence of post&#x2010;coronavirus disease 2019 (COVID&#x2010;19) condition or long COVID: a meta&#x2010;analysis and systematic review. J Infect Dis 2022; 226: 1593&#x2010;1607.</Citation></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators; Wulf Hanson S, Abbafati C, Aerts JG, et&#xa0;al. Estimated global proportions&#xa0;of&#xa0;individuals with persistent fatigue, cognitive,&#xa0;and respiratory symptom clusters&#xa0;following symptomatic COVID&#x2010;19 in&#xa0;2020&#xa0;and 2021. JAMA 2022; 328: 1604&#x2010;1615.</Citation></Reference><Reference><Citation>Office for National Statistics (UK). New&#x2010;onset, self&#x2010;reported long COVID after coronavirus (COVID&#x2010;19) reinfection in the UK: 23 February 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/newonsetselfreportedlongcovidaftercoronaviruscovid19reinfectionintheuk/23february2023 (viewed Apr 2023).</Citation></Reference><Reference><Citation>Woldegiorgis M, Cadby G, Ngeh S, et&#xa0;al. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS&#x2010;CoV&#x2010;2 Omicron wave: a cross&#x2010;sectional survey. Med J Aust 2024; 220: 323&#x2010;330. https://www.mja.com.au/journal/2024/220/6/long&#x2010;covid&#x2010;highly&#x2010;vaccinated&#x2010;largely&#x2010;unexposed&#x2010;australian&#x2010;population&#x2010;following</Citation></Reference><Reference><Citation>Liu B, Jayasundara D, Pye V, et&#xa0;al. Whole of population&#x2010;based cohort study of recovery time from COVID&#x2010;19 in New South Wales Australia. Lancet Reg Health West Pac 2021; 12: 100193.</Citation></Reference><Reference><Citation>Biddle N, Korda R. The experience of COVID&#x2010;19 in Australia, including long COVID &#x2014; evidence from the COVID&#x2010;19 Impact Monitoring Survey series, August 2022. Canberra: Australian National University, 2022. https://csrm.cass.anu.edu.au/research/publications/experience&#x2010;covid&#x2010;19&#x2010;australia&#x2010;including&#x2010;long&#x2010;covid&#x2010;evidence&#x2010;covid&#x2010;19&#x2010;impact (viewed Sept 2023).</Citation></Reference><Reference><Citation>Reuschke D, Houston D. The impact of long COVID on the UK workforce. Appl Econ Lett 2022; 30: 2510&#x2010;2514.</Citation></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum 2022; 3: e221809.</Citation></Reference><Reference><Citation>MSD. A neglected burden: the ongoing economic costs of COVID&#x2010;19 in Australia. Sydney: MSD, 2023. https://www.msd&#x2010;australia.com.au/wp&#x2010;content/uploads/sites/19/2023/10/MSD_A&#x2010;neglected&#x2010;burden_Impact&#x2010;of&#x2010;COVID&#x2010;19&#x2010;in&#x2010;Australia.pdf (viewed Jan 2024).</Citation></Reference><Reference><Citation>Australian Bureau of Statistics. Labour force, Australia. Canberra: ABS, 2023. https://www.abs.gov.au/statistics/labour/employment&#x2010;and&#x2010;unemployment/labour&#x2010;force&#x2010;australia/aug&#x2010;2023 (viewed Sept 2023).</Citation></Reference><Reference><Citation>Angeles M, Hensher M. Estimating the current scale and impact of long COVID in Australia. Melbourne: Deakin University, 2022. https://iht.deakin.edu.au/wp&#x2010;content/uploads/sites/153/2022/11/LC&#x2010;Modelling&#x2010;full&#x2010;report.pdf (viewed Sept 2023).</Citation></Reference><Reference><Citation>Angeles MR, Wanni Arachchige Dona S, Nguyen HD, et&#xa0;al. Modelling the potential acute and post&#x2010;acute burden of COVID&#x2010;19 under the Australian border re&#x2010;opening plan. BMC Public Health 2022; 22: 757.</Citation></Reference><Reference><Citation>Office for National Statistics (UK). Self&#x2010;reported long COVID after infection with the Omicron variant in the UK: 18 July 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022 (viewed Apr 2023).</Citation></Reference><Reference><Citation>Office for National Statistics (UK). Technical article: updated estimates of the prevalence of post&#x2010;acute symptoms among people with coronavirus (COVID&#x2010;19) in the UK: 26 April 2020 to 1 August 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021 (viewed Sept 2022).</Citation></Reference><Reference><Citation>Mathieu E, Ritchie H, Rod&#xe9;s&#x2010;Guirao L, et&#xa0;al. Coronavirus pandemic (COVID&#x2010;19). https://ourworldindata.org/coronavirus (viewed Sept 2022).</Citation></Reference><Reference><Citation>NSW Health. NSW respiratory surveillance reports &#x2014; COVID&#x2010;19 and influenza. https://www.health.nsw.gov.au/Infectious/covid&#x2010;19/Pages/weekly&#x2010;reports.aspx (viewed Apr 2023).</Citation></Reference><Reference><Citation>EpiGear International. Ersatz Version 1.3. Brisbane: EpiGear International, 2016. https://www.epigear.com/index_files/ersatz.html (viewed Oct 2022).</Citation></Reference><Reference><Citation>Zhao T, Cox IA, Ahmad H, et&#xa0;al. The economic burden of myalgic encephalomyelitis/chronic fatigue syndrome in Australia. Aust Health Rev 2023; 47: 707&#x2010;715.</Citation></Reference><Reference><Citation>House of Representatives Standing Committee on Health, Aged Care and Sport. Sick and tired: casting a long shadow. Inquiry into long COVID and repeated COVID infections. Canberra: Commonwealth of Australia, 2023. https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/LongandrepeatedCOVID/Report (viewed Jan 2024).</Citation></Reference><Reference><Citation>Australian Bureau of Statistics. Australian national accounts: national income, expenditure and product. Canberra: ABS, 2023. https://www.abs.gov.au/statistics/economy/national&#x2010;accounts/australian&#x2010;national&#x2010;accounts&#x2010;national&#x2010;income&#x2010;expenditure&#x2010;and&#x2010;product/mar&#x2010;2023#cite&#x2010;window1 (viewed Sept 2023).</Citation></Reference><Reference><Citation>Australian Bureau of Statistics. Barriers and incentives to labour force participation, Australia. Canberra: ABS, 2022. https://www.abs.gov.au/statistics/labour/employment&#x2010;and&#x2010;unemployment/barriers&#x2010;and&#x2010;incentives&#x2010;labour&#x2010;force&#x2010;participation&#x2010;australia/2020&#x2010;21 (viewed Sept 2023).</Citation></Reference><Reference><Citation>Australian Bureau of Statistics. Potential workers. Canberra: Australian Bureau of Statistics, 2023. https://www.abs.gov.au/statistics/labour/employment&#x2010;and&#x2010;unemployment/potential&#x2010;workers/feb&#x2010;2023 (viewed Sept 2023).</Citation></Reference><Reference><Citation>Australian Government Department of Social Services. DSS benefit and payment recipient demographics &#x2013; quarterly data. Canberra: DSS, 2023. https://data.gov.au/data/dataset/dss&#x2010;payment&#x2010;demographic&#x2010;data (viewed Sept 2023).</Citation></Reference><Reference><Citation>Staples LG, Nielssen O, Dear BF, et&#xa0;al. Prevalence and predictors of long COVID in patients accessing a national digital mental health service. Int J Environ Res Public Health 2023; 20: 6756.</Citation></Reference><Reference><Citation>Bullock M. Achieving full employment [speech]. Sydney: Reserve Bank of Australia, 2023. https://www.rba.gov.au/speeches/2023/sp&#x2010;dg&#x2010;2023&#x2010;06&#x2010;20.html (viewed Sept 2023).</Citation></Reference><Reference><Citation>Australian Government Treasury. Funding the Australian Bureau of Statistics to better collect data on disadvantage [media release]. Canberra: Australian Government, 2022. https://ministers.treasury.gov.au/ministers/andrew&#x2010;leigh&#x2010;2022/media&#x2010;releases/funding&#x2010;australian&#x2010;bureau&#x2010;statistics&#x2010;better&#x2010;collect&#x2010;data (viewed Sept 2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>